Article

Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication: a clinical study.

2023-10-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Reports on eradication of non-<italic>Helicobacter pylori Helicobacter</italic> (NHPH) gastritis in Japanese patients are rare. We investigated effectiveness of the standard triple-drug combination therapy for <italic>Helicobacter pylori</italic> eradication and of proton pump inhibitor (PPI) monotherapy in eradication of non-<italic>Helicobacter pylori Helicobac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7c4906ac-4759-52cd-8a54-c1d6ffcf1f37
DOI: 10.21203/rs.3.rs-3302116/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication: a clinical study.DOI 10.21203/rs.3.rs-3302116/v1Read

Treatment of Helicobacter pylori infection: Where are we now?Semantic proximity Read

Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure EraSemantic proximity Read

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Semantic proximity Read

Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infectionSemantic proximity Read

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.Semantic proximity Read

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Semantic proximity Read

Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeuticsSemantic proximity Read

Antibiotic resistance of Helicobacter pylori in Nanjing, China: A cross-section study from 2018 to 2023Semantic proximity Read

Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Semantic proximity Read

Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective studySemantic proximity Read

Efficacy of 14-day vonoprazan-amoxicillin dual therapy compared to esomeprazole-amoxicillin dual therapy for eradication of Helicobacter pylori in treatment-naïve patientsSemantic proximity Read

Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.Semantic proximity Read